Moody's: Baxter unchanged

Moody's Investors Service said that Baxter International Inc.'s A3 rating and stable outlook remain unchanged at this time following the Food and Drug Administration's request that the company recall approximately 200,000 of its Colleague infusion pumps.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.